Mechanisms to medicines in neurodegeneration
Molecular Neuroscience, Neuropharmacology, Neuroscience and seminar by Professor Giovann Mallucci, Department of Clinical Neurosciences, University of Cambridge
Hosted by Cambridge Neuro
Tuesday 15:00–16:10 London (GMT+0)
Recording available
Abstract
Dysregulation of protein synthesis both globally and locally in neurons and astrocytes is a key feature of neurodegenerative diseases. Aberrant signalling through the Unfolded Protein Response (UPR) and related Integrated Stress Response (ISR) have become major targets for neuroprotection in these disorders. In addition, other homeostatic mechanisms and stress responses, including the cold shock response, appear to regulate local translation and RNA splicing to control synapse maintenance and regeneration and can also be targeted therapeutically for neuroprotection. We have defined the role of UPR/ISR and the cold-shock response in neurodegenerative disorders and have developed translational strategies targeting them for new treatments for dementia.
Topics
Show 1 more topic
Related seminars
- Video page · Nov 23, 2020Luis Barbeito, MD, Responsable Científico, Laboratorio de Neurodegeneración, Instituto Pasteur Montevideo
Targeting the synapse in Alzheimer’s Disease
Video page · Dec 14, 2020Johanna Jackson, UK Dementia Research Institute at Imperial College LondonHuman stem cell models of neurodegeneration: complex, relevant and robust
Video · 31 min · Jul 22, 2021Clare Jones, Talisman Therapeutics
More from Cambridge Neuro
All talksImmunosuppression for Parkinson's disease - a new therapeutic strategy?
Video page · May 30, 2023Caroline Williams-GrayFeedback control in the nervous system: from cells and circuits to behaviour
Video page · May 16, 2023Timothy O'LearyTargeting Maladaptive Emotional Memories to Treat Mental Health Disorders: Insights from Rodent Models
Video page · May 9, 2023Amy MiltonFragile minds in a scary world: trauma and post traumatic stress in very young children
Video page · Mar 14, 2023Tim Dalgleish